Cargando…

Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions

The membrane proteins of viruses play critical roles in the virus life cycle and are attractive targets for therapeutic intervention. Virus-like particles (VLP) present the possibility to study the biochemical and biophysical properties of viral membrane proteins in their native environment. Specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antanasijevic, Aleksandar, Kingsley, Carolyn, Basu, Arnab, Bowlin, Terry L., Rong, Lijun, Caffrey, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826305/ https://www.ncbi.nlm.nih.gov/pubmed/26921030 http://dx.doi.org/10.1007/s10858-016-0025-1

Ejemplares similares

Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021)

Zika virus-like particle (VLP) based vaccine
por: Boigard, Hélène, et al.
Publicado: (2017)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
por: Klimek, Ludger, et al.
Publicado: (2018)

On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP
por: Roldão, António, et al.
Publicado: (2012)

VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display
por: Sari‐Ak, Duygu, et al.
Publicado: (2021)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017)

Inhibition of Influenza H7 Hemagglutinin-Mediated Entry
por: Antanasijevic, Aleksandar, et al.
Publicado: (2013)

Characterization of Influenza Hemagglutinin Interactions with Receptor by NMR
por: McCullough, Christopher, et al.
Publicado: (2012)

A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration
por: Wolf, Tobias, et al.
Publicado: (2022)

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
por: Huber, Bettina, et al.
Publicado: (2017)

A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system
por: Pankrac, Joshua, et al.
Publicado: (2018)

Virus-like Particle (VLP) Mediated Antigen Delivery as a Sensitization Tool of Experimental Allergy Mouse Models
por: Kim, Juhyung, et al.
Publicado: (2020)

Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry
por: Wang, Jizhen, et al.
Publicado: (2011)

Identification of a pH sensor in Influenza hemagglutinin using X-ray crystallography
por: Antanasijevic, Aleksandar, et al.
Publicado: (2020)

Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas
por: Govan, Vandana A, et al.
Publicado: (2008)

Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
por: Garg, Himanshu, et al.
Publicado: (2020)

Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains
por: Chu, Ki-Back, et al.
Publicado: (2021)

Structure of avian influenza hemagglutinin in complex with a small molecule entry inhibitor
por: Antanasijevic, Aleksandar, et al.
Publicado: (2020)

Preparation of SARS-CoV-2 VLP to study viral assembly, egress, and entry
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement
por: Schmidt, Frederik L., et al.
Publicado: (2021)

Development of a novel platform of virus-like particle (VLP)-based vaccine against COVID-19 by exposing epitopes: an immunoinformatics approach
por: Ghorbani, A., et al.
Publicado: (2020)

Structures, Dynamics, and Functions of Viral Membrane Proteins by NMR
por: Basso, Luis G., et al.
Publicado: (2018)

Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP)
por: Fernandez, F.M., et al.
Publicado: (1996)

RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021)

LB18. An Enveloped Virus-like Particle (eVLP) Cytomegalovirus (CMV) Vaccine Is Immunogenic and Safe: Results of a First-in-Humans Study
por: Gantt, Soren, et al.
Publicado: (2018)

Viral Protein VP1 Virus-like Particles (VLP) of CVB4 Induces Protective Immunity against Lethal Challenges with Diabetogenic E2 and Wild Type JBV Strains in Mice Model
por: Gharbi, Jawhar, et al.
Publicado: (2023)

Scan Pattern Characterization of Velodyne VLP-16 Lidar Sensor for UAS Laser Scanning
por: Lassiter, H. Andrew, et al.
Publicado: (2020)

Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines
por: Fernandez, F.M., et al.
Publicado: (1998)

Discovery of Selective Inhibitors of the Clostridium difficile Dehydroquinate Dehydratase
por: Ratia, Kiira, et al.
Publicado: (2014)

Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)
por: Dye, John M., et al.
Publicado: (2016)

Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus
por: Braz Gomes, Kimberly, et al.
Publicado: (2021)

Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery
por: Gomes, Keegan Braz, et al.
Publicado: (2022)

An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line
por: Hirschberg, Stefan, et al.
Publicado: (2023)

Large-scale production and purification of VLP-based vaccines
por: Vicente, Tiago, et al.
Publicado: (2011)

Construction and Characterization of Insect Cell-Derived Influenza VLP: Cell Binding, Fusion, and EGFP Incorporation
por: Pan, Yi-Shin, et al.
Publicado: (2010)

Crystal Structures of Type I Dehydroquinate Dehydratase in Complex with Quinate and Shikimate Suggest a Novel Mechanism of Schiff Base Formation
por: Light, Samuel H., et al.
Publicado: (2014)

The Vacuolar Morphogenesis Protein Vam6-Like Protein Vlp1 Is Required for Pathogenicity of Cryptococcus neoformans
por: Fan, Cheng-Li, et al.
Publicado: (2021)

Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display
por: Crossey, Erin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g58jo8bd0ijtj20d8jdc5srcia